Khunti K, Griffin S, Brennan A, Dallosso H, Davies MJ, Eborall HC, Edwardson CL, Gray LJ, Hardeman W, Heathcote L, Henson J, Pollard D, Sharp SJ, Sutton S, Troughton J, and Yates T
BMC medicine. Mar 2021
(DOI : 10.1186/s12916-021-01997-4)
Chudasama YV, Zaccardi F, Gillies CL, Razieh C, Yates T, Kloecker DE, Rowlands AV, Davies MJ, Islam N, Seidu S, Forouhi NG, and Khunti K
BMC infectious diseases. Sep 2020
(DOI : 10.1186/s12879-021-06600-y)
Diabetic medicine : a journal of the British Diabetic Association. Jun 2020
(DOI : 10.1111/dme.14342)
Chan JCN, Lim LL, Wareham NJ, Shaw JE, Orchard TJ, Zhang P, Lau ESH, Eliasson B, Kong APS, Ezzati M, Aguilar-Salinas CA, McGill M, Levitt NS, Ning G, So WY, Adams J, Bracco P, Forouhi NG, Gregory GA, Guo J, Hua X, Klatman EL, Magliano DJ, Ng BP, Ogilvie D, Panter J, Pavkov M, Shao H, Unwin N, White M, Wou C, Ma RCW, Schmidt MI, Ramachandran A, Seino Y, Bennett PH, Oldenburg B, Gagliardino JJ, Luk AOY, Clarke PM, Ogle GD, Davies MJ, Holman RR, and Gregg EW
Lancet (London, England). Nov 2019
(DOI : 10.1016/S0140-6736(20)32374-6)
Griffin SJ, Rutten GEHM, Khunti K, Witte DR, Lauritzen T, Sharp SJ, Dalsgaard EM, Davies MJ, Irving GJ, Vos RC, Webb DR, Wareham NJ, and Sandbæk A
The lancet. Diabetes & endocrinology. Nov 2018
(DOI : 10.1016/S2213-8587(19)30349-3)
BMC Public Health. Mar 2018
(DOI : 10.1186/s12889-018-6341-5)
A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study.
Simmons RK, Borch-Johnsen K, Lauritzen T, Rutten GE, Sandbæk A, van den Donk M, Black JA, Tao L, Wilson EC, Davies MJ, Khunti K, Sharp SJ, Wareham NJ, and Griffin SJ
Health technology assessment (Winchester, England). Sep 2016
(DOI : 10.3310/hta20640)
Diabetes/metabolism research and reviews. Aug 2016
(DOI : 10.1002/dmrr.2877)
PRomotion Of Physical activity through structured Education with differing Levels of ongoing Support for people at high risk of type 2 diabetes (PROPELS): study protocol for a randomized controlled trial.
Yates T, Griffin S, Bodicoat DH, Brierly G, Dallosso H, Davies MJ, Eborall H, Edwardson C, Gillett M, Gray L, Hardeman W, Hill S, Morton KL, Sutton S, Troughton J, and Khunti K
Trials. Mar 2015
(DOI : 10.1186/s13063-015-0813-z)
Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial.
Diabetic medicine : a journal of the British Diabetic Association. Feb 2015
(DOI : 10.1111/dme.12711)
BMJ open diabetes research & care. Dec 2014
(DOI : 10.1136/bmjdrc-2014-000075)
Early Detection and Treatment of Type 2 Diabetes Reduce Cardiovascular Morbidity and Mortality: A Simulation of the Results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe).
Herman WH, Ye W, Griffin SJ, Simmons RK, Davies MJ, Khunti K, Rutten GE, Sandbaek A, Lauritzen T, Borch-Johnsen K, Brown MB, and Wareham NJ
Diabetes care. Oct 2014
(DOI : 10.2337/dc14-2459)
Effect of early multifactorial therapy compared with routine care on microvascular outcomes at 5 years in people with screen-detected diabetes: a randomized controlled trial: the ADDITION-Europe Study.
Diabetes care. May 2014
(DOI : 10.2337/dc13-1544)
The British journal of general practice : the journal of the Royal College of General Practitioners. Apr 2014
(DOI : 10.3399/bjgp14X677833)
Diabetic medicine : a journal of the British Diabetic Association. Sep 2013
(DOI : 10.1111/dme.12410)
Diabetes-specific quality of life but not health status is independently associated with glycaemic control among patients with type 2 diabetes: a cross-sectional analysis of the ADDITION-Europe trial cohort.
Diabetes Research and Clinical Practice. Jun 2013
(DOI : 10.1016/j.diabres.2013.12.029)
Effect of early intensive multifactorial therapy compared with routine care on self-reported health status, general well-being, diabetes-specific quality of life and treatment satisfaction in screen-detected type 2 diabetes mellitus patients (ADDITION-Europe): a cluster-randomised trial.
van den Donk M, Griffin SJ, Stellato RK, Simmons RK, Sandbæk A, Lauritzen T, Khunti K, Davies MJ, Borch-Johnsen K, Wareham NJ, and Rutten GE
Diabetologia. Apr 2013
(DOI : 10.1007/s00125-013-3011-0)
Diabetic medicine : a journal of the British Diabetic Association. Jul 2012
(DOI : 10.1111/j.1464-5491.2012.03759.x)
Diabetic medicine : a journal of the British Diabetic Association. Oct 2011
(DOI : 10.1111/j.1464-5491.2011.03478.x)
Diabetic medicine : a journal of the British Diabetic Association. Sep 2011
(DOI : 10.1111/j.1464-5491.2011.03441.x)
Lancet (London, England). Jun 2011
(DOI : 10.1016/S0140-6736(11)60698-3)
Diabetic medicine : a journal of the British Diabetic Association. Jun 2011
(DOI : 10.1111/j.1464-5491.2011.03365.x)
Webb DR, Gray LJ, Khunti K, Srinivasan B, Taub N, Campbell S, Barnett J, Farooqi A, Echouffo-Tcheugui JB, Griffin SJ, Wareham NJ, and Davies MJ
Diabetologia. Oct 2010
(DOI : 10.1007/s00125-011-2189-2)
Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening.
Webb DR, Khunti K, Srinivasan B, Gray LJ, Taub N, Campbell S, Barnett J, Henson J, Hiles S, Farooqi A, Griffin SJ, Wareham NJ, and Davies MJ
Trials. Nov 2009
(DOI : 10.1186/1745-6215-11-16)